ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668329 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668329; 2) Community: the network communities that were significantly associated with the response to NSC 668329; 3) Molecule: the relationships between components within communities and NSC 668329; 4) MDR: the compounds that were significantly associated with the NSC 668329.

NSC Compound Enrichment Correlation
NSC 749518 1-[(2Z)-3-amino-3-phenylprop-2-enoyl]-3-phenyl-1H-pyrazol-5-amine 0.0295480456086947 0.1228092
NSC 752703 Null 0.0295480456086947 0.24880977
NSC 753187 4-chloro-N-(4-(3-(4-chloro-3-methoxyphenyl)-4-(pyridin-4-yl)-1H-pyrazol-1-yl)phenyl)-3-(trifluoromethyl)benzamide 0.0295480456086947 -0.079087544
NSC 754596 6-imino-3-methoxy 4-azaisoindole[2,1-a]quinoxaline 0.0295480456086947 0.049489434
NSC 758706 Simvastatin (USAN) 0.0295480456086947 0.033099005
NSC 760015 E)-1-(4-(quinazolin-4-ylamino)phenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one 0.0295480456086947 0.055725957
NSC 762009 Copper(II) complex with quin as a ligand 0.0295480456086947 0.24177577
NSC 113951 6-Bromotoyocamycin 0.0314734733353265 0.2431199
NSC 330500 Macbecin II 0.0314734733353265 0.23987325
NSC 609699 Topotecan hydrochloride 0.0314734733353265 0.10536659
Total:97  Current:77    [First] [Prev] [Next] [Last]